Human AKT1 (RAC-alpha serine/threonine-protein kinase) ELISA Kit

Este producto es parte de AKT1 - RAC-alpha serine/threonine-protein kinase 1
Product Graph
Contáctenos para saber el precio

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
Human AKT1 (RAC-alpha serine/threonine-protein kinase) ELISA Kit
category
ELISA Kits
provider
FineTest
reference
EH0532
tested applications
ELISA

Documents del producto

Instrucciones
Descargar
Data sheet

Product specifications

Category
ELISA Kits
Reactivity
Human
Detection Method
Colorimetric
Assay Data
4 hours
Assay Type
Sandwich ELISA, Double Antibody
Test Range
0.156-10ng/ml
Sensitivity
0.094ng/ml
Size 1
96T
Tested Applications
ELISA
Sample Type
Serum, Plasma, Cell Culture Supernatant, cell or tissue lysate, Other liquid samples
Availability
Shipped within 10-14 working days.
Storage
2-8 °C for 12 months
UniProt ID
P31749
Alias
AKT1,PKB,RAC,RAC-ALPHA
Background
Elisa kits for AKT1
Status
RUO

The AKT (also known as Protein Kinase B) is a pivotal enzyme involved in regulating various cellular processes like metabolism, proliferation, survival, and growth. It acts downstream of phosphoinositide 3-kinase (PI3K) signaling pathway, which is activated by growth factors and cytokines. RAC-alpha serine/threonine-protein kinase is the full name of AKT. It belongs to the AGC (protein kinase A/protein kinase G/protein kinase C) family of kinases. AKT has three isoforms: AKT1, AKT2, and AKT3. Each isoform has slightly different tissue distributions and roles but shares the same basic structure and mechanism of action.Activation of AKT typically occurs through phosphorylation at two key residues: threonine 308 (Thr308) and serine 473 (Ser473). Once activated, AKT phosphorylates various downstream targets, including transcription factors, metabolic enzymes, and cell cycle regulators, ultimately leading to diverse cellular responses. Dysregulation of AKT signaling is implicated in various diseases, including cancer, diabetes, and cardiovascular diseases. Therefore, AKT has emerged as a significant target for therapeutic interventions in these conditions.

Related Products

EH0532

Human AKT1 (RAC-alpha serine/threonine-protein kinase) ELISA Kit

Ver Producto
EM1294

Mouse AKT1 (RAC-alpha serine/threonine-protein kinase) ELISA Kit

Ver Producto
ER1268

Rat AKT1 (RAC-alpha serine/threonine-protein kinase) ELISA Kit

Ver Producto